Abiopharma

Director Amouyal Philippe 🟢 acquired 79.2K shares (2 derivative) of LEXICON PHARMACEUTICALS, INC. (LXRX) at $1.61 Transaction Date: May 01, 2026 | Filing ID: 000092

📋 Atlas Venture Associates XI, LP (Shareholder) plans to sell 61 shares of Dyne Therapeutics, Inc. (at $17.39 each, total $1K) Filed: May 04, 2026 | ID: 029907

(99% Neutral) INNOVIVA, INC. (INVA) Announces Regulatory Update

REED JOHN C 🟡 adjusted position in 11.0K shares (1 derivative) of JOHNSON & JOHNSON (JNJ) at $229.85 ($2.5M) Transaction Date: May 01, 2026 | Filing ID: 000115

STICE J MICHAEL 🟢 acquired 728 shares of Marathon Petroleum Corp (MPC) Transaction Date: Apr 30, 2026 | Filing ID: 204242

(99% Neutral) ST JOE CO (JOE) Announces Business Combination

Director RUBINSTEIN JONATHAN 🔴 sold 3.7K shares of AMAZON COM INC (AMZN) at $273.02 ($1.0M) Transaction Date: Apr 30, 2026 | Filing ID: 000008

(30% Negative) GREAT ELM CAPITAL CORP. (GECC) Reports Q2 2026 Financial Results

(80% Positive) TENNANT CO (TNC) Reports Q2 2026 Financial Results

Director Mat Ishbia 🟡 adjusted position in 2.9M shares (1 derivative) of UWM Holdings Corp (UWMC) at $3.62 ($10.5M) Transaction Date: Apr 30, 2026 | Filing ID: 000069